1/5
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Ambrisentan
Don’t use in moderate to severe hepatic impairment
Macitentan
NO renal or hepatic adjustments
Bosentan
Avoid initiating if moderate to severe hepatic impairment
Tadalafil
CrCl < 30 mL/min: avoid use
Mild to moderate hepatic impairment: use with caution (initial dose 20 mg daily)
Severe hepatic impairment: avoid use
Riociguat
CrCl < 15 mL/min or on dialysis: avoid use
Severe hepatic impairment: avoid use
Treprostinil PO
Mild hepatic impairment: start 0.125 mg BID, increase every 3 to 4 days by 0.125 mg
Moderate hepatic impairment: avoid use
Severe hepatic impairment: CONTRAINDICATED